STOCKHOLDERS' EQUITY (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| STOCKHOLDERS' EQUITY |
|
| Schedule of designation, shares authorized, and shares outstanding for the Company's Preferred Stock |
| | | | | | | | | | | | Preferred Shares | | Preferred Shares | | Potentially Issuable | Preferred Stock Series Designation | | Authorized | | Outstanding | | Preferred Shares | Series Seed | | | 213,000,000 | | | 204,772,940 | | | 8,227,060 | Series A | | | 207,000,000 | | | 185,440,880 | | | 21,559,120 | Series T | | | 99,000,000 | | | 9,642,080 | | | 89,357,920 |
|
| Schedule of inputs valued under using the Black-Scholes pricing model |
| | | | | | 2026 | | Expected life (years) | | 6.5 | | Risk-free interest rate | | 4.0 | % | Expected volatility | | 54.6 | % | Annual dividend yield | | 0 | % |
|
| Schedule of stock option activity and related information |
| | | | | | | | | | | | Options | | | Weighted- Average Exercise Price | | | Aggregate Intrinsic Value | Outstanding at December 31, 2025 | | | 158,828,223 | | $ | 0.59 | | $ | - | Granted | | | 12,410,000 | | | 1.60 | | | - | Exercised | | | (48,077) | | | 0.22 | | | 66,507 | Forfeited | | | (4,316,346) | | | 1.26 | | | - | Expired | | | - | | | - | | | - | Outstanding at June 30, 2026 | | | 166,873,800 | | $ | 0.65 | | $ | - | Exercisable at June 30, 2026 | | | 125,468,810 | | $ | 0.46 | | $ | - |
|
| Schedule of stock option expense |
| | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Cost of revenues | | $ | 375,116 | | $ | 284,101 | | $ | 803,858 | | $ | 600,068 | General and administrative | | | 520,005 | | | 496,707 | | | 1,040,278 | | | 968,289 | Sales and marketing | | | 925,827 | | | 1,309,059 | | | 2,298,603 | | | 2,684,039 | Research and development | | | 518,244 | | | 436,569 | | | 1,034,721 | | | 925,122 | Total | | $ | 2,339,192 | | $ | 2,526,436 | | $ | 5,177,460 | | $ | 5,177,518 |
|